SIGNIFOR LAR

This brand name is authorized in Australia, Canada, Ecuador, Hong Kong, Israel, Japan, New Zealand, Singapore, South Africa

Active ingredients

The drug SIGNIFOR LAR contains one active pharmaceutical ingredient (API):

1 Pasireotide UNII 04F55A7UZ3 - PASIREOTIDE PAMOATE

Pasireotide is a novel cyclohexapeptide, injectable somatostatin analogue. Pasireotide exerts its pharmacological activity via binding to somatostatin receptors. Somatostatin receptors are expressed in many tissues, especially in neuroendocrine tumours in which hormones are excessively secreted, including ACTH in Cushing’s disease. Read about Pasireotide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SIGNIFOR LAR Suspension for injection	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01CB05	Pasireotide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CB Somatostatin and analogues
Discover more medicines within H01CB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10880P, 10882R, 10883T, 10884W, 10886Y, 10887B
Country: CA	Health Products and Food Branch	Identifier(s): 02437252, 02437260, 02437279, 02480425, 02480433
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1898-MEE-0316, 2063-MEE-0516, 2166-MEE-0516
Country: HK	Department of Health Drug Office	Identifier(s): 64743, 64744, 64745
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7793, 7794, 7795, 9343, 9344
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499417G1023, 2499417G2020, 2499417G3026, 2499417G4022, 2499417G5029
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 18804, 18856, 18857
Country: SG	Health Sciences Authority	Identifier(s): 15168P, 15169P, 15170P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 49/32/0272, 49/32/0273, 49/32/0274